| ARREX | VGSIX | ARREX / VGSIX | |
| Total Expense Ratio | 0.95 | 0.27 | 352% |
| Annual Report Gross Expense Ratio | 0.95 | 0.27 | 352% |
| Fund Existence | 9 years | 30 years | - |
| Gain YTD | 1.613 | 1.326 | 122% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 501M | 64B | 1% |
| Annual Yield % from dividends | 2.30 | 3.68 | 62% |
| Returns for 1 year | 1.95 | 3.04 | 64% |
| Returns for 3 years | 11.80 | 9.55 | 124% |
| Returns for 5 years | 5.78 | 22.14 | 26% |
| Returns for 10 years | N/A | 65.86 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DMAT | 33.31 | 1.65 | +5.21% |
| Global X Disruptive Materials ETF | |||
| MYCF | 25.03 | 0.01 | +0.02% |
| State Street® My2026 Corporate Bond ETF | |||
| IAPR | 31.30 | N/A | -0.01% |
| Innovator Intl Dev Pwr Bffr ETF Apr | |||
| BMEZ | 15.26 | -0.04 | -0.26% |
| BlackRock Health Sciences Term Trust | |||
| AVGX | 39.19 | -2.73 | -6.51% |
| Defiance Daily Target 2X Long AVGO ETF | |||